APA aipamena

Elfiky, A. A. (2020). Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]. Life Sci.

Chicago Style aipamena

Elfiky, Abdo A. "Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA Dependent RNA Polymerase (RdRp): A Molecular Docking Study” [Life Sci. 253 (2020) 117592]." Life Sci 2020.

MLA aipamena

Elfiky, Abdo A. "Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA Dependent RNA Polymerase (RdRp): A Molecular Docking Study” [Life Sci. 253 (2020) 117592]." Life Sci 2020.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.